In market activity today, Aptose Biosciences Inc shares closed at $1.99 after opening the day at $2.10. Intraday prices ranged from a low of $1.99 to a high of $2.26.

The price eased -4.33% from the previous day's close of $2.08.

Today across North America, the TSX Composite closed -0.50% at 22075.10, the S&P 500 closed -0.72% at 5205.81, the Dow Jones Industrial Average closed -1.00% at 39170.24 and the Nasdaq Composite closed -0.95% at 16240.45.

Aptose Biosciences Inc has listed on the Toronto Stock Exchange (TSX) under the ticker APS.

Trading volume was 38,254 on 135 total trades, while having an average volume of 14,606 over the last 5-days.

Trading across the entire TSX saw 2,968 price advancers against 2,262 declines and 117 unchanged.

During the prior 52 weeks, APS.TO has traded as high as $12.45 (April 04,2023) and low as $1.85 (March 14,2024). Moreover, in the last 52 weeks, Aptose Biosciences Inc's shares have plummeted -84.21%, while they have shrunken -40.60% this year.

Following today's trading, Aptose Biosciences Inc has a market capitalization of $32.69 million on a float of 15,718 shares outstanding. Its annual EPS is $-7.58.

Aptose Biosciences Inc is a TSX Biotechnology company headquartered in Toronto, CAN.

Currently, Aptose Biosciences Inc's consensus rating is "Strong Buy" based on 3 analysts according to Zacks. From those 3 analysts, 3 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..